« Back

Eye drug maker Alimera Sciences Inc. has completed a $30 million Series C funding from its existing investors and acquired a majority stake in one of its development projects. Alimera stakeholders include Scale Venture Partners of Foster City, Calif., Domain Associates of Princeton, N.J., Intersouth Partners of Durham, N.C., Polaris Venture Partners of Waltham, Mass., and Venrock Associates of Menlo Park, Calif. The new funds will allow Alimera to pay $12 million in cash, plus a $15 million note and other future milestone considerations, to acquire a majority stake in Medidur FA, a diabetic macular edema treatment Alimera has been developing in partnership with pSivida Ltd. of Perth, Australia. Alimera had previously raised about $58.5 million in two rounds dating back to 2004.

« Back